Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02736981 · ClinicalTrials.gov registry record · NA

Low Intensity Weight Loss for Young Adults

A NA study, sponsored by Virginia Commonwealth University.

Completed
Registry status
NA
Development phase
382
Enrollment target

NCT02736981: Completed NA study, sponsored by Virginia Commonwealth University.

NCT02736981 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 382 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02736981, a NA study, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
NA
Development phase
382 participants
Enrollment target

Study Summary

This is a 3-arm randomized controlled trial to test the efficacy of three novel motivational approaches to weight loss with 18-25 year olds. Participants will be 18-25 year olds with a BMI of 25-45 kg/m2, randomized to: 1) Behavioral Weight Loss (BWL), 2) BWL + Autonomous Motivation (BWL+Aut) or 3) BWL + Extrinsic Motivation (BWL+Ext). All arms will receive a 6-month behavioral weight loss intervention, followed by a 6-month no-treatment follow up period.

Primary Outcome

Primary pre-specified outcome is weight change in kilograms from baseline to 6 months. Change in kg was used in power calculations.

Interventions

  • BEHAVIORAL Behavioral Weight Loss (BWL)
  • BEHAVIORAL BWL + Autonomous Motivation
  • BEHAVIORAL BWL + Extrinsic Motivation

Trial Details

FieldValue
Enrollment Target 382 participants
Start Date 2016-01
Est. Completion 2020-02-08
Phase NA
Virginia Commonwealth University

558 total trials

What the finished NCT02736981 record still lists

NCT02736981 is an interventional study that assigns participants to a tested intervention. The registered 382 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower).

The record links to 0 conditions, and to 3 interventions - of which Behavioral Weight Loss (BWL) is the first listed.

NCT02736981 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02736981 about?

NCT02736981 is a clinical study titled "Low Intensity Weight Loss for Young Adults". This is a 3-arm randomized controlled trial to test the efficacy of three novel motivational approaches to weight loss with 18-25 year olds. Participants will be 18-25 year olds with a BMI of 25-45 kg/m2, randomized to: 1) Behavioral Weight Loss (BWL), 2) BWL + Autonomous Motivation (BWL+Aut) or 3) ...

What is the current status of trial NCT02736981?

This trial is currently completed. It is a NA study. The enrollment target is 382 participants. The study started on 2016-01. Estimated completion is 2020-02-08.

What interventions are being tested in trial NCT02736981?

The interventions under investigation include: Behavioral Weight Loss (BWL) (BEHAVIORAL), BWL + Autonomous Motivation (BEHAVIORAL), BWL + Extrinsic Motivation (BEHAVIORAL).

Who is sponsoring clinical trial NCT02736981?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02736981's enrollment target sits among peer trials

382 273rd of 2000 higher than 1,728 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05677490 · 382 participants · Phase 3

    mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

  • NCT06196008 · 382 participants · NA

    Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers

  • NCT07100990 · 382 participants · Phase 3

    Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)

  • NCT06056830 · 383 participants · Phase 3

    Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02736981, the US trial registry maintained by the National Library of Medicine. NCT02736981 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.